About NOWDiagnostics
NOWDiagnostics is a company based in Bentonville (United States) founded in 2013. NOWDiagnostics has raised $65.69 million across 5 funding rounds from investors including LabCorp, DigitalDX Ventures and Kompass Kapital. The company has 28 employees as of December 31, 2022. NOWDiagnostics has completed 2 acquisitions, including Cellmic and ZBx Corporation. NOWDiagnostics offers products and services including First To Know® Syphilis Test, ADEXUSDx® hCG Test, and First To Know® Pregnancy Test (EU). NOWDiagnostics operates in a competitive market with competitors including OpGen, Avails Medical, Resistell, HandyLab and GNA Biosolutions, among others.
- Headquarter Bentonville, United States
- Employees 28 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nowdiagnostics Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NOWDiagnostics
NOWDiagnostics offers a comprehensive portfolio of products and services, including First To Know® Syphilis Test, ADEXUSDx® hCG Test, and First To Know® Pregnancy Test (EU).
Over-the-counter test for rapid syphilis detection at home.
Home test for detecting pregnancy through hormone analysis.
Over-the-counter test for pregnancy in European markets.
People of NOWDiagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of NOWDiagnostics
NOWDiagnostics has successfully raised a total of $65.69M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $22.5 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NOWDiagnostics
NOWDiagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, DigitalDX Ventures and Kompass Kapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
DigitalDX Ventures is focused on AI and healthcare innovation investments.
|
Locked | Locked | Locked | |
|
Private fund focused on debt, equity, and fund of funds investments
|
Locked | Locked | Locked | |
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked |
Investor details for NOWDiagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NOWDiagnostics
NOWDiagnostics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cellmic and ZBx Corporation.
Investment portfolio details for NOWDiagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Rapid test readers are developed for chromatographic and fluorescent assays.
|
Locked | Locked | 2009 | Locked | |
|
Point-of-care diagnostic products for clinical testing are developed and marketed.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for NOWDiagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NOWDiagnostics
Detailed financials for NOWDiagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nowdiagnostics Comparisons
Peer comparison for NOWDiagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NOWDiagnostics
NOWDiagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Avails Medical, Resistell, HandyLab and GNA Biosolutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| Locked | Locked | Locked |
Antibiotic susceptibility testing is provided via bacterial movement detection.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays and automation platforms are developed.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
Detailed competitors of NOWDiagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nowdiagnostics
Complete news archive for NOWDiagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NOWDiagnostics
NOWDiagnostics was founded in 2013.
NOWDiagnostics is headquartered in Bentonville, United States. It is registered at Bentonville, Arkansas, United States.
NOWDiagnostics is a funded company, having raised a total of $65.69M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at NOWDiagnostics is 28.
NowDiagnostics, formerly known as HomeDx develops and manufactures diagnostic tests that offer POC rapid test reader. Its ADEXUSDx product line uses a single drop of blood to test for a variety of common conditions, illnesses and diseases with quick results. It received FDA clearance for hCG test and is conducting two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.
NOWDiagnostics's top competitors include Avails Medical, OpGen and Verax Biomedical.
NOWDiagnostics offers First To Know® Syphilis Test, ADEXUSDx® hCG Test, and First To Know® Pregnancy Test (EU).
NOWDiagnostics has made 2 acquisitions, including Cellmic, and ZBx Corporation.
NOWDiagnostics has 3 investors. Key investors include LabCorp, DigitalDX Ventures, and Kompass Kapital.